Stemedica Cell Technologies, Inc. was founded as the result of a personal commitment to find alternatives for a family member who had been severely paralyzed from an automobile accident

The Company’s mission is to apply the regenerative powers of adult stem cells to save, restore and improve the quality of lives for millions who are afflicted with neurodegenerative diseases and other debilitating conditions including those that cause blindness.

A specialty biopharmaceutical company, Stemedica has created a unique family of life-changing cells that doctors use to treat “no option” patients. A “no option” patient is someone who has exhausted all traditional forms of medical treatment and therapy and whose recovery and well being have plateaued or declined. These patients are treated at hospitals and clinics that are exclusively licensed to use Stemedica's stem cell lines.

The Company supports these Licensed Treatment Centers with: professional, onsite medical and technical staff; standard operating procedures and quality assurance; treatment protocols; physician training; and, patient education.

Stemedica's technology is based on over 30 years of pioneering stem cell research and treatment experience. This includes over 2,000 patients treated in Russia and an additional 1,800 patients that have been treated by our partners across Europe.

From this rich history of innovation and clinical success, Stemedica recruited over 40 of the world's leading scientists and physicians to form a joint venture between premier research institutions, universities and hospitals in Russia, United States, France, Italy, Switzerland, Korea, Japan and the Ukraine. Through the cooperative efforts of these institutions, scientists and physicians, Stemedica has developed "industry first" innovations and has realized unparalleled restorative successes for patients from all over the world.

The successful transfer and on-going advancement of the Company’s technology, know-how and first-hand clinical experience have enabled Stemedica to become the leader in the adult stem cell field. The Company's founders, directors, scientists, physicians and strategic partners are committed to continuous innovation in pursuit of saving, restoring and improving quality of life for those afflicted with incurable diseases and debilitating conditions.